Duchenne Muscular Dystrophy Treatment Market Estimated to Witness...

added blog Other

2024-09-26 13:47:05 - Translate -

Duchenne Muscular Dystrophy Treatment Market Estimated to Witness High Growth

The global Duchenne muscular dystrophy treatment market is estimated to be valued at US$ 2 billion in 2024 and is expected to exhibit a CAGR of 47% over the forecast period 2024-2028.Key TakeawaysKey players operating in the Duchenne muscular dystrophy treatment are Sarepta Therapeutics, Pfizer, PTC Therapeutics, Summit Therapeutics, and others. Sarepta Therapeutics' Exondys 51 was the first...

0 Comments 0 Shares 335 Views 0 Reviews